Nisa Investment Advisors’s Fennec Pharmaceuticals FENC Stock Holding History

Nisa Investment Advisors’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$283	Hold	46	–	–	﹤0.01%	2941
2025 Q4	$354	Hold	46	–	–	﹤0.01%	2861
2025 Q3	$431	Hold	46	–	–	﹤0.01%	2873
2025 Q2	$382	Sell	46 -181	-80%	-$1.24K	﹤0.01%	2910
2025 Q1	$1.38K	Sell	227 -150	-40%	-$963	﹤0.01%	2555
2024 Q4	$2.38K	Buy	377 +108	+40%	+$553	﹤0.01%	2440
2024 Q3	$1.34K	Buy	269 +200	+290%	+$1.16K	﹤0.01%	2503
2024 Q2	$422	Buy	+69	New	+$573	﹤0.01%	2726
2021 Q2	–	Sell	-1,500	Closed	-$9	–	2343
2021 Q1	$9	Hold	1,500	–	–	﹤0.01%	2217
2020 Q4	$11K	Buy	+1,500	New	+$11.4K	﹤0.01%	2200

Other funds holding FENC

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

SCA

Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return

SCM

Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PCM

Potomac Capital Management New York $115M AUM

Nisa Investment Advisors's FENC Position: Q1 2026 in Review

Nisa Investment Advisors held its Fennec Pharmaceuticals (FENC) position steady in Q1 2026 at 46 shares worth $283. The position accounts for ﹤0.01% of the portfolio, ranked #2941.

Nisa Investment Advisors first reported a position in FENC in Q4 2020 and has held it in 10 quarters since. The position peaked at $11K in Q4 2020. 90 funds tracked by Wall St. Rank hold FENC as of Q1 2026.

Nisa Investment Advisors held 46 shares of Fennec Pharmaceuticals worth $283 as of Q1 2026.
Nisa Investment Advisors left its Fennec Pharmaceuticals share count unchanged in Q1 2026.
Fennec Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2941 holding.
Nisa Investment Advisors first reported a position in Fennec Pharmaceuticals in Q4 2020 and has held it in 10 quarters since.
Nisa Investment Advisors's Fennec Pharmaceuticals position peaked at $11K in Q4 2020.
90 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.